Advertisement

Life expectancy is unaffected by thyroid function parameters in euthyroid subjects: The PREVEND cohort study

Published:November 06, 2017DOI:https://doi.org/10.1016/j.ejim.2017.10.017

      Highlights

      • Low-normal thyroid function within the euthyroid range may impact on health.
      • Whether differences in TSH, FT4 and FT3 influence life expectancy is unknown.
      • 2431 euthyroid subjects were followed for 13 years; 218 subjects died.
      • Life expectancy did not vary according to tertiles of TSH, FT4 and FT3.
      • Low-normal thyroid function does not influence life expectancy in euthyroid subjects.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Taylor P.N.
        • Razvi S.
        • Pearce S.H.
        • Dayan C.M.
        Clinical review: a review of the clinical consequences of variation in thyroid function within the reference range.
        J Clin Endocrinol Metab. 2013; 98: 3562-3571
        • Tienhoven-Wind van
        • Dullaart R.P.
        Low-normal thyroid function and novel cardiometabolic biomarkers.
        Nutrients. 2015; 16: 1352-1377
        • Åsvold B.O.
        • Vatten L.J.
        • Bjøro T.
        • Bauer D.C.
        • Bremner A.
        • Cappola A.R.
        • et al.
        Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts.
        JAMA Intern Med. 2015; 175: 1037-1047
        • Chaker L.
        • Ligthart S.
        • Korevaar T.I.
        • Hofman A.
        • Franco O.H.
        • Peeters R.P.
        • et al.
        Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study.
        BMC Med. 2016; 14: 150
        • Chaker L.
        • Baumgartner C.
        • den Elzen W.P.
        • Collet T.H.
        • Ikram M.A.
        • Blum M.R.
        • et al.
        Thyroid function within the reference range and the risk of stroke: an individual participant data analysis.
        J Clin Endocrinol Metab. 2016; 101: 4270-4282
        • Chaker L.
        • van den Berg M.E.
        • Niemeijer M.N.
        • Franco O.H.
        • Dehghan A.
        • Hofman A.
        • et al.
        Thyroid function and sudden cardiac death: a prospective population-based cohort study.
        Circulation. 2016; 134: 713-722
        • Khan S.R.
        • Chaker L.
        • Ruiter R.
        • Aerts J.G.
        • Hofman A.
        • Dehghan A.
        • et al.
        Thyroid function and cancer risk: the Rotterdam study.
        J Clin Endocrinol Metab. 2016; 101: 5030-5036
        • Roos A.
        • Bakker S.J.
        • Links T.P.
        • Gans R.O.
        • Wolffenbuttel B.H.
        Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.
        J Clin Endocrinol Metab. 2007; 92: 491-496
        • Links T.P.
        • van Tol K.M.
        • Jager P.L.
        • Plukker J.T.
        • Piers D.A.
        • Boezen H.M.
        • et al.
        Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis.
        Endocr Relat Cancer. 2005; 12: 273-280
        • van Dijk D.
        • Plukker J.T.
        • van der Horst-Schrivers A.N.
        • Jansen L.
        • Brouwers A.H.
        • Muller-Kobold A.
        • et al.
        The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial 131I therapy.
        Clin Endocrinol (Oxf). 2011; 74: 104-110